Czynnik XII (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Czynnik XII" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
5th place
2nd place

doi.org

dx.doi.org

  • D E Cool, R T A MacGillivray, CHARACTERIZATION OF THe HUMAN FACTOR XII GENE, „Thromb Haemost”, 58 (01), XIth International Congress on Thrombosis and Haemostasis, Schattauer GmbH, 1987, s. 001, DOI10.1055/s-0038-1642800 [dostęp 2020-11-28].
  • Renné T, Schmaier AH, i inni. In vivo roles of factor XII, „Blood”, 120 (22), 2012, s. 4296–4303, DOI10.1182/blood-2012-07-292094, PMID22993391, PMCIDPMC3507141.
  • Müller F, Mutch NJ, Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo, „Cell”, 139 (6), 2009, s. 1143–1156, DOI10.1016/j.cell.2009.11.001, PMID20005807, PMCIDPMC2796262.
  • E Stavrou, AH Schmaier, Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis, „Thrombosis Research”, 125 (3), 2010, s. 210–5, DOI10.1016/j.thromres.2009.11.028, PMID20022081, PMCIDPMC2851158.
  • DX Beringer, LM Kroon-Batenburg, The structure of the FnI-EGF-like tandem domain of coagulation factor XII solved using SIRAS, „Acta Crystallographica Section F.”, 69 (Pt 2), 2013, s. 94–102, DOI10.1107/S1744309113000286, PMID23385745, PMCIDPMC3564606.
  • A Dementiev, A Silva, Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors, „Blood Advances”, 2 (5), 2018, s. 549–558, DOI10.1182/bloodadvances.2018016337, PMID29519898, PMCIDPMC5851424.
  • Pathak M, Wilmann P, Coagulation factor XII protease domain crystal structure, „Journal of Thrombosis and Haemostasis”, 13 (4), 2015, s. 580–91, DOI10.1111/jth.12849, PMID25604127, PMCIDPMC4418343.
  • National Organization for Rare Disorders (NORD), „SpringerReference”, Berlin/Heidelberg: Springer-Verlag, DOI10.1007/springerreference_184269 [dostęp 2020-11-28].
  • Walter-Michael Halbmayer i inni, The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors, „Thromb Haemost”, 71 (1), 1994, s. 68–72, DOI10.1055/s-0038-1642386, PMID8165648.
  • Wagenman BL, Townsend KT, The laboratory approach to inherited and acquired coagulation factor deficiencies, „Clinics in Laboratory Medicine”, 29 (2), 2009, s. 229–252, DOI10.1016/j.cll.2009.04.002, PMID19665676.
  • Pauer HU, Burfeind P, Factor XII deficiency is strongly associated with primary recurrent abortions, „Fertility and Sterility”, 80 (3), 2003, s. 590–594, DOI10.1016/S0015-0282(03)00788-X, PMID12969703.
  • Cichon S, Martin L, Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type III, „American Journal of Human Genetics”, 79 (6), 2006, s. 1098–1104, DOI10.1086/509899, PMID17186468, PMCIDPMC1698720.
  • ALVIN MARGOLIUS, OSCAR D. RATNOFF, Observations on the Hereditary Nature of Hageman Trait, „Blood”, 11 (6), 1956, s. 565–569, DOI10.1182/blood.v11.6.565.565, ISSN 0006-4971 [dostęp 2020-11-28].

nih.gov

ncbi.nlm.nih.gov

  • Renné T, Schmaier AH, i inni. In vivo roles of factor XII, „Blood”, 120 (22), 2012, s. 4296–4303, DOI10.1182/blood-2012-07-292094, PMID22993391, PMCIDPMC3507141.
  • Müller F, Mutch NJ, Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo, „Cell”, 139 (6), 2009, s. 1143–1156, DOI10.1016/j.cell.2009.11.001, PMID20005807, PMCIDPMC2796262.
  • E Stavrou, AH Schmaier, Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis, „Thrombosis Research”, 125 (3), 2010, s. 210–5, DOI10.1016/j.thromres.2009.11.028, PMID20022081, PMCIDPMC2851158.
  • DX Beringer, LM Kroon-Batenburg, The structure of the FnI-EGF-like tandem domain of coagulation factor XII solved using SIRAS, „Acta Crystallographica Section F.”, 69 (Pt 2), 2013, s. 94–102, DOI10.1107/S1744309113000286, PMID23385745, PMCIDPMC3564606.
  • A Dementiev, A Silva, Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors, „Blood Advances”, 2 (5), 2018, s. 549–558, DOI10.1182/bloodadvances.2018016337, PMID29519898, PMCIDPMC5851424.
  • Pathak M, Wilmann P, Coagulation factor XII protease domain crystal structure, „Journal of Thrombosis and Haemostasis”, 13 (4), 2015, s. 580–91, DOI10.1111/jth.12849, PMID25604127, PMCIDPMC4418343.
  • Walter-Michael Halbmayer i inni, The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors, „Thromb Haemost”, 71 (1), 1994, s. 68–72, DOI10.1055/s-0038-1642386, PMID8165648.
  • Wagenman BL, Townsend KT, The laboratory approach to inherited and acquired coagulation factor deficiencies, „Clinics in Laboratory Medicine”, 29 (2), 2009, s. 229–252, DOI10.1016/j.cll.2009.04.002, PMID19665676.
  • Pauer HU, Burfeind P, Factor XII deficiency is strongly associated with primary recurrent abortions, „Fertility and Sterility”, 80 (3), 2003, s. 590–594, DOI10.1016/S0015-0282(03)00788-X, PMID12969703.
  • Cichon S, Martin L, Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type III, „American Journal of Human Genetics”, 79 (6), 2006, s. 1098–1104, DOI10.1086/509899, PMID17186468, PMCIDPMC1698720.

worldcat.org

  • ALVIN MARGOLIUS, OSCAR D. RATNOFF, Observations on the Hereditary Nature of Hageman Trait, „Blood”, 11 (6), 1956, s. 565–569, DOI10.1182/blood.v11.6.565.565, ISSN 0006-4971 [dostęp 2020-11-28].